Prevention of invasive fungal infections in patients with acute myeloid leukaemia: results of a single centre retrospective observational study with the use of posaconazole versus conventional mould-active azoles.
Chiara Maria
CM
Dellacasa
Alessandro
A
Busca
Ernesta
E
Audisio
Filippo
F
Marmont
Anna Maria
AM
Barbui
Michele
M
Falda
Francesco Giuseppe
FG
De Rosa
Chiara
C
Frairia
Bernardino
B
Allione
Stefano
S
D'Ardia
Semra
S
Aydin
Clara
C
Pecoraro
Sara
S
Manetta
Umberto
U
Vitolo
D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D000368:Aged; D000935:Antifungal Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D015331:Cohort Studies; D005260:Female; D006801:Humans; D017964:Itraconazole / Q000008:administration & dosage / Q000627:therapeutic use*; D015470:Leukemia, Myeloid, Acute / Q000150:complications* / Q000188:drug therapy / Q000382:microbiology; D008297:Male; D008875:Middle Aged; D009181:Mycoses / Q000150:complications* / Q000382:microbiology / Q000517:prevention & control*; D012189:Retrospective Studies; D014230:Triazoles / Q000008:administration & dosage / Q000627:therapeutic use*; D055815:Young Adult
D000935:Antifungal Agents; D014230:Triazoles; D017964:Itraconazole; C101425:posaconazole